Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
Aadel A. Chaudhuri(Stanford University), Chad Tang(Stanford University), Michael S. Binkley(Stanford University), Michelle Jin(Stanford University), Jacob Wynne(Stanford University), Rie von Eyben(Stanford University), Wendy Hara(Stanford University), Nicholas Trakul(Stanford University), Billy W. Loo(Stanford University), Maximilian Diehn(Stanford University)
Cited by 176
Abstract
Related Papers
Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer
Cornelis J.A. Haasbeek, Frank J. Lagerwaard, Ben J. Slotman et al.|Journal of Thoracic Oncology|2011|259
Stereotactic Body Radiation Therapy in Centrally and Superiorly Located Stage I or Isolated Recurrent Non–Small-Cell Lung Cancer
Joe Y. Chang, Peter Balter, Lei Dong et al.|International Journal of Radiation Oncology*Biology*Physics|2008|258
Comparative Effectiveness of 5 Treatment Strategies for Early-Stage Non-Small Cell Lung Cancer in the Elderly
Shervin M. Shirvani, Jing Jiang, Joe Y. Chang et al.|International Journal of Radiation Oncology*Biology*Physics|2012|252